Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice
Abstract Aging is associated with cognitive decline, and currently, there are no approved medications that can prevent these impairments. Recently,…
Abstract Aging is associated with cognitive decline, and currently, there are no approved medications that can prevent these impairments. Recently,…
Abstract Hippocampal encephalitis (HE), or more generally limbic encephalitis, can be secondary to various etiologies. Through this case, we report…
Abstract Synthetic cannabinoid use raises concerns about its neuroinflammatory effects, including molecular adaptations of the endocannabinoid system (ECS) in the…
Abstract Deficits in learning and memory are some of the most commonly reported symptoms following a traumatic brain injury (TBI).…
Abstract A combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) at non-psychoactive doses was previously demonstrated to reduce cognitive decline in…
Abstract Post-traumatic stress disorder (PTSD) is the most common psychiatric disorder after a catastrophic event; however, the efficacious treatment options…
Abstract Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene…
Abstract Cannabis use is increasing rapidly among young people worldwide despite the deleterious effects of this toxic substance on health.…
Abstract Glucocorticoid hormones cortisol and corticosterone (collectively called CORT), secreted as the end products of the hypothalamus-pituitary-adrenal (HPA)-axis, coordinate body…
Abstract Fear refers to an adaptive response in the face of danger, and the formed fear memory acts as a…